GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome Activation

Shanshan Dai1, Bozhi Ye2, Lingfeng Zhong2

  • 1The Key Laboratory of Emergency and Disaster Medicine of Wenzhou, Department of Emergency, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Insights

Gasdermin D (GSDMD) fragment GSDMD-NT contributes to sepsis-induced myocardial dysfunction by damaging mitochondria. Blocking GSDMD protects cardiac function and improves survival in septic mice.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Sepsis-induced myocardial dysfunction is a major cause of mortality.
  • The precise molecular mechanisms underlying sepsis-induced cardiac dysfunction remain incompletely understood.
  • Gasdermin D (GSDMD) has emerged as a key mediator of inflammatory cell death.

Purpose of the Study:

  • To investigate the role of GSDMD in the development of cardiac dysfunction during sepsis.
  • To elucidate the molecular mechanisms by which GSDMD contributes to myocardial injury in sepsis.
  • To evaluate GSDMD as a potential therapeutic target for sepsis-induced myocardial dysfunction.

Main Methods:

  • Lipopolysaccharide (LPS) was used to induce sepsis in wild-type (WT) and GSDMD-knockout (Gsdmd-/-) C57BL/6 mice.
  • Cardiac function was assessed by measuring ejection fraction (EF) and fractional shortening (FS).
  • Myocardial injury markers (cTnI, CK-MB, LDH), inflammatory cytokines (IL-1β, TNF-α), mitochondrial function, reactive oxygen species (ROS) production, and NF-κB/NLRP3 inflammasome activation were analyzed.

Main Results:

  • LPS-induced sepsis led to increased GSDMD-NT in cardiac tissue, decreased cardiac function, and elevated myocardial injury markers in WT mice.
  • Gsdmd-/- mice showed protection against LPS-induced cardiac dysfunction, reduced myocardial injury, and improved survival rates.
  • GSDMD deficiency attenuated inflammatory responses, suppressed NF-κB and NLRP3 inflammasome activation, and prevented mitochondrial dysfunction and ROS overproduction in the myocardium.

Conclusions:

  • GSDMD plays a critical role in the pathogenesis of sepsis-induced myocardial dysfunction.
  • GSDMD-NT contributes to cardiac injury by inducing mitochondrial dysfunction and ROS production, thereby activating the NLRP3 inflammasome.
  • Targeting GSDMD may represent a promising therapeutic strategy for managing sepsis-induced myocardial dysfunction.

Related Concept Videos